Dermatological Therapeutics Market, By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Other Applications), By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other Drug Classes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Market for dermatological therapeutics was valued at US$ 30365 million in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 8.90% to reach US$ 71024 million by 2030.

Dermatology is a medical specialty that addresses skin, nails, and hair-related issues, including psoriasis, pigmentation, acne, and wrinkles. Topical skin care products are known as dermatological or dermatologological agents. These products are used to prevent certain skin illnesses and to treat a wide range of skin ailments. Dermatological products are also used for routine skin care to maintain the health of one's skin. Conversely, certain dermatological preparations are systemic and are used on patients who do not react to topical therapy. In addition, these mixtures are used to treat psoriasis, dermatitis, and acne, among other skin conditions. Numerous nations worldwide have faced and are still facing substantial financial and medical burdens due to COVID-19's high transmission rate. The production facilities of all healthcare-related businesses were devastated by the COVID-19 pandemic 2020, and transportation suffered greatly in both developed and developing nations. The dermatological market is expected to encounter direct and indirect repercussions over the forecast period.